Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides

Bioorg Med Chem. 2010 Jul 1;18(13):4812-20. doi: 10.1016/j.bmc.2010.05.002. Epub 2010 May 31.

Abstract

On the basis of potent anti-hepatitis C virus (HCV) activity of 2'-C-hydroxymethyladenosine, 3'-C-substituted-methyl-ribofuranosyl pyrimidine and purine nucleosides were designed and synthesized from D-xylose. Among compounds tested, all adenine analogues, 4a, 4d, and 4g showed significant anti-HCV activity in a replicon-based cell assay irrespective of the substituent (Y=OH, N₃, or F) at the 3'-C-substituted methyl position, among which 4g (Y=N₃) was the most potent, but it is also cytotoxic. This study guarantees the 3'-C-substituted-methyl nucleoside serves as a new template for the development of new anti-HCV agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / chemical synthesis
  • Adenosine / chemistry
  • Adenosine / pharmacology
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology
  • Hepacivirus / drug effects*
  • Purine Nucleosides / chemical synthesis
  • Purine Nucleosides / chemistry*
  • Purine Nucleosides / pharmacology
  • Pyrimidine Nucleosides / chemical synthesis
  • Pyrimidine Nucleosides / chemistry*
  • Pyrimidine Nucleosides / pharmacology
  • Virus Replication / drug effects

Substances

  • (3beta-C-fluoromethyl-beta-D-ribofuranosyl)-N6-methyladenine
  • (3betaC-fluoromethyl-beta-D-ribofuranosyl)adenine
  • Antiviral Agents
  • Purine Nucleosides
  • Pyrimidine Nucleosides
  • Adenosine